Wednesday, 26th October
3rd Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity 2022
Days
Sunday, 23rd October
Monday, 24th October
Tuesday, 25th October
Wednesday, 26th October
Search
Speakers
Plenary Session 4
8:30AM - 9:30AM
Wednesday, 26th October
Chair: Zane Andrews
CNS-dependent control of metabolism
-
Jens C. Bruening
Session 7: Neural Control of Metabolism
9:30AM - 11:00AM
Wednesday, 26th October
Chairs: Sarah Lockie & Yanchuan Shi
Mechanism of Amphetamine-Induced Weight Loss
-
Michael Cowley
Hunger drives life
-
Tamas Horvath
New Frontiers in the Treatment of Obesity
-
Kendra Bence
Morning Tea and Networking
11:00AM - 11:30AM
Wednesday, 26th October
Session 8: Comorbidities of Obesity & Diabetes
11:30AM - 1:00PM
Wednesday, 26th October
Chairs: Rachel Perry & Renea Taylor
Dissecting the role of fatty acid bunding protein in obesity-driven hepatocellular carcinoma
-
Carlos Fernandez Hernando
Novel Targets in Diabetic Kidney Disease
-
Karin Jandeleit-Dahm
Emerging Epidemics of Obesity and Cancer: Can We Break the Link?
-
Rachel Perry
Lunch Break
1:00PM - 2:00PM
Wednesday, 26th October
Session 9: Metabolic Dysfunction
2:00PM - 4:15PM
Wednesday, 26th October
Chairs: Carlos Fernandez Hernando & Aneta Stefanidis
The dysfunctional metabolism in diabetes and obesity dysregulates the TET2-AMPK axis and accelerates DNMT3A clonal haematopoiesis
-
Andrew Murphy
Nutrient Sensing and Inter-organ Crosstalk
-
Xiaoyong Yang
Mouse strain-dependent variation in the NASH lipidome - Novel therapeutic avenues for NAFLD
-
Magdalene Montgomery
Hypothalamic neurofibrosis promotes metabolic disease
-
Garron T Dodd
Conditional Muscle Specific Loss of PolG mtDNA Proof Reading Capacity Induces Profound Changes to Muscle and Systemic Homeostasis
-
Brian G Drew
Genome-wide association study of the human lipidome provides new insight to lipid metabolism and cardiometabolic disease
-
Peter J Meikle
Closing Ceremony and Award Presentation
4:15PM - 4:30PM
Wednesday, 26th October
← Tuesday